Heron Therapeutics SG&A Expense (Quarterly) Trends

Heron Therapeutics Inc (HRTX)

2.635 -0.08 (-2.95%) USD | NASDAQ | Apr 19, 16:00

2.635 0.00 (0.00%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 1989. Upgrade now.

Date	Value
December 31, 2023	23.62M
September 30, 2023	24.60M
June 30, 2023	36.44M
March 31, 2023	32.01M
December 31, 2022	26.70M
September 30, 2022	28.18M
June 30, 2022	32.12M
March 31, 2022	32.96M
December 31, 2021	34.37M
September 30, 2021	34.99M
June 30, 2021	33.16M
March 31, 2021	24.81M
December 31, 2020	28.06M
September 30, 2020	22.00M
June 30, 2020	25.41M
March 31, 2020	30.62M
December 31, 2019	30.29M
September 30, 2019	25.57M
June 30, 2019	33.42M
March 31, 2019	38.37M
December 31, 2018	28.70M
September 30, 2018	23.57M
June 30, 2018	20.74M
March 31, 2018	20.86M
December 31, 2017	22.85M

Date	Value
September 30, 2017	19.99M
June 30, 2017	20.96M
March 31, 2017	18.36M
December 31, 2016	18.54M
September 30, 2016	17.49M
June 30, 2016	15.78M
March 31, 2016	17.22M
December 31, 2015	14.80M
September 30, 2015	8.25M
June 30, 2015	6.839M
March 31, 2015	5.856M
December 31, 2014	5.30M
September 30, 2014	4.222M
June 30, 2014	4.512M
March 31, 2014	5.694M
December 31, 2013	5.477M
September 30, 2013	6.448M
June 30, 2013	4.403M
March 31, 2013	5.612M
December 31, 2012	3.476M
September 30, 2012	2.428M
June 30, 2012	1.313M
March 31, 2012	1.44M
December 31, 2011	1.263M
September 30, 2011	1.16M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

22.00M

Minimum

Sep 2020

36.44M

Maximum

Jun 2023

29.44M

Average

30.29M

Median

Dec 2019

SG&A Expense (Quarterly) Benchmarks